Clinical trial and testing solutions that are both patient-centric and flexibly aligned with your program’s goals

Fortrea is your dedicated partner that offers solutions suited to your needs from early phase trial design through commercialization

Our cross-functional support and customized strategies help accelerate your timelines and get your therapy to market faster

Advance ocular therapies with a CRO that offers personalized services that span from early phase trial design through commercialization.

Strategic vision for your ophthalmic program.

  • Rely on our ophthalmic staff’s deep scientific and regulatory experience from delivering more than 100 global, patient-centric ophthalmology clinical trials for emerging biotech companies over the last five years
  • Work with renowned vision scientists to handle ocular needs and deliver specialized expertise in the ocular surface, and anterior and posterior segments
  • Enable intelligent patient recruitment with advanced data and increase efficiencies with our established relationships with more than 2,000 global sites

Extend your team’s expertise.

Experience counts when it comes to placing patients' needs at the forefront of your decisions and ensuring the success of your ophthalmology studies. Our expertise and insights at Fortrea have helped advance more than 100 clinical ophthalmology studies over the last five years as we’ve provided flexible solutions for emerging and mid-sized biotech companies.

Fortrea’s cross-functional support and customized strategies accelerate development timelines, anticipate and prevent issues and get ophthalmic therapies to market. Together, our robust partnership can help your team improve patient lives faster.

Unique solutions for clinical trials and testing.

Fortrea’s delivery is centered around clinical trial solutions that are both patient-centric and flexibly aligned with your program’s needs.

  • Accelerate patient recruitment and site identification – Fortrea leverages data to help you make informed clinical trial decisions, with unique programs to integrate both patient- and site voice into protocol design and deployment through our experienced investigator sites that are part of our tracked and trusted network
  • Gain scientific and regulatory support – Extend your team’s capabilities with Fortrea’s regulatory and commercial guidance. Count on our extensive experience in assisting both small biotech and large pharmaceutical companies to help achieve your strategic goals
  • Apply flexible, integrated delivery models – Whether you need to apply a decentralized clinical trial approach to mitigate delivery risks, or take advantage of Fortrea’s full service or functional service provider models, we work together to optimize your delivery


We design our delivery capabilities to match your preference and the needs of your project. Take advantage of these comprehensive full-service solutions while we track your project’s milestones and data.

Delivering expertise with OSOD.

Advance your ophthalmic program with a consortium of more than 40 internationally respected vision scientists. We have worked with OSOD to help emerging biotechs and large pharmaceutical companies work with vision science experts, such as board-certified veterinary ophthalmologists, electrophysiologists (for electroretinograms), veterinary and physician pathologists, clinicians and professional ocular photographers, as well as basic scientists in a wide range of ocular science areas.

Your team will receive unsurpassed vision science consulting — spanning study design, data acquisition/interpretation, clinical translation, and regulatory strategies — and benefit from state-of-the-art instrumentation for comprehensive descriptive and functional evaluation of your endpoints.

Optimizing trials and focusing on the path to commercialization.

Solutions for ocular surface and anterior segment studies

Get expert support for trials involving the ocular surface and the anterior segment. From cataracts, glaucoma, and dry eye to allergy and inflammation, as well as contact and intraocular lens, we apply our lessons learned from supporting numerous studies across several key indications.

Solutions for the posterior segment studies

Rely on our retinal specialists’ experience in global studies spanning macular degeneration, diabetic retinopathy, retinitis pigmentosa, vitreomacular adhesion, proliferative vitreoretinopathy and inflammation. We also offer unique expertise in ocular rare disease and ophthalmic cell and gene therapies.

Propel studies with robust patient recruitment, engagement and retention.

With a strategy tailored to each ocular disease indication, Fortrea’s holistic approach starts with established site relationships to find the strongest, high-performing sites for each study and leverage existing agreements to expedite startup. Our team of dedicated subject matter experts provides a comprehensive, data-driven site and patient engagement strategy that incorporates best practices gleaned from previous and current ophthalmology trial experience.

Once your trial is underway, you can rely on Fortrea’s ocular clinical trial management team to provide close communication and collaboration. We work to identify certified vendors that perform visual acuity assessments and central reads of ocular imaging. We also, use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

Intelligent recruitment, inspiring science and integrated delivery.

Advance your study with a contract research organization that provides clinical, scientific, regulatory and operational perspectives coupled with ophthalmic experienced teams that keep the patient at the forefront of your design decisions. From site selection to patient recruitment strategies and generation of quality data, we are here to help you reduce the the burden on patients and sites, mitigate risks and optimize your processes throughout your program.

Stay up to date:
Subscribe for Fortrea news & announcements.